Topics
Technologies
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long...
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team...
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by...
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by...
Policies
The title of this book is clever, not least because it is borrowed from a very secret society of a...
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them...
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy...
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to...
Society
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health...
Our report Fertility, Embryo Research and Genome Editing: Public Attitudes in Europe explores public attitudes to fertility treatment, embryo research, ...
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers...
In 2017, a 33-year-old political philosopher named Iason Gabriel was told by a friend that he ought to apply for a...
Perspectives
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have...
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic...
As Edward Donnell Ivy remembers it, many of the sickle cell episodes he endured in his 20s were akin to headaches...
Imagine wanting to have a child and discovering, at every stage, that the system was not designed with you in...